Loading clinical trials...
Loading clinical trials...
A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed Dose Combination in Adolescents and Children With Chronic HCV Infection
Conditions
Interventions
SOF/VEL/VOX
Locations
10
Italy
SOS-intraSOC Epatologia
Florence, Italy
Servizio di Epatologia e Nutrizione Pediatrica
Milan, Italy
US Infettivologia Pediatrica-Polo Universitario
Milan, Italy
UOS Epatologia Pediatrica
Naples, Italy
UOSD Epatologia
San Giovanni Rotondo, Italy
Wojewodzki Szpital
Bydgoszcz, Poland
Start Date
January 28, 2019
Primary Completion Date
December 4, 2019
Completion Date
February 19, 2020
Last Updated
October 23, 2020
NCT06718530
NCT05361603
NCT05975216
NCT05071261
NCT05906459
NCT04980157
Lead Sponsor
Gilead Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions